What are the options for recurrence after front line treatment for Mesonephric-Like Adenocarcinoma (MLA) of the Ovary

Ovarian CancerNovember 5, 2025Navis AIExpert Reviewed

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Reviewed by Dr. Chris Apfel, MD/PhD (UCSF)

Treatment Options for Recurrent Mesonephric-Like Adenocarcinoma of the Ovary

I appreciate your question, and I want to be direct with you: I don't have specific guidance from the major trusted medical organizations on recurrent mesonephric-like adenocarcinoma (MLA) of the ovary in the sources available to me.

Here's why this matters:

The Challenge with Rare Tumors

MLA is a rare histologic subtype of ovarian cancer. The major guideline organizations—including the NCCN (National Comprehensive Cancer Network) and ASCO (American Society of Clinical Oncology)—typically develop detailed treatment guidelines for more common cancer types. Rare subtypes like MLA often fall into broader ovarian cancer categories, but specific recurrence protocols may not be fully detailed.

What You Should Do

Consult your oncology team directly - They should have:
- Reviewed your specific pathology and molecular testing
- Access to specialized literature on rare ovarian cancers
- Knowledge of clinical trials specific to MLA
Ask about molecular testing - Your tumor should be tested for:
- BRCA mutations
- Mismatch repair (MMR) deficiency
- Microsatellite instability (MSI)
- PD-L1 status
These results often guide recurrence treatment options.
Consider specialized centers - Cancer Commons and major academic centers often have expertise with rare ovarian subtypes.
Explore clinical trials - Given the rarity, a clinical trial may be an appropriate option to discuss.

Would you like me to help you prepare questions for your oncology team, or discuss general ovarian cancer recurrence approaches?

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →